Pacific RxTracts - December 2025

Authors

Pacific RxTracts

Files

Description

Articles:

• FDA Approves Nerandomilast: A New Era in Idiopathic Pulmonary Fibrosis Treatment
• Brand New Approach to Addressing the Unmet Need of Cholestatic Pruritus
• Prep for Success with Lactulose
• Caution with Reported Allergies: Increased Risk of Surgical Site Infection with Non-β-Lactam Antibiotics
• Eltrombopag Redefines Treatment for Newly Diagnosed Pediatric ITP Combination for Extensive-Stage Small Cell
• Advancing Treatment for HER2-Positive Breast Cancer: Trastuzumab Deruxtecan plus Pertuzumab
• Comparison in Efficacy of Abiraterone and Enzalutamide in US Veterans with mHSPC
• Revumenib: A First-in-Class Menin Inhibitor for Relapsed or Refractory Acute Myeloid Leukemia
• Ziftomenib: A Menin Inhibitor Redefining Precision Therapy in NPM1-Mutated AML
• The Future of Convenient Obesity Treatment
• Optimizing Glycemic Control in Pregnancies
• The Rise of Dual Neurokinin Blockade: Elinzanetant as a Novel Solution for VMS
• Balancing Symptom Relief and Survival in Dementia Hospice Medication Management
• Enlicitide: The First Oral PCSK9 Therapy in Phase 3 Evaluation

Publication Date

12-3-2025

Volume

23

Issue

3

Pages

9

Publisher

University of the Pacific

City

Stockton, CA

Disciplines

Medicine and Health Sciences | Pharmacy and Pharmaceutical Sciences

Recommended Citation

Pacific RxTracts, "Pacific RxTracts - December 2025" (2025). Pacific RxTracts. 12.
https://scholarlycommons.pacific.edu/rx-tracts/12